{"filing":{"accession_number":"0001493152-26-030236","cik":"0001828673","ticker":"HCWB","company_name":"HCW Biologics Inc.","form":"8-K","filing_date":"2026-06-26","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1828673/000149315226030236/form8-k.htm"},"events":[{"id":14132,"run_id":12570,"accession_number":"0001493152-26-030236","anchor_item_number":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"summary":"HCW Biologics disclosed a 1-for-6 reverse stock split effectuated in direct response to a Nasdaq Hearings Panel decision letter (May 29, 2026) that threatened \"automatic delisting\" if the company failed to maintain compliance with the Bid Price Rule (minimum $1.00 per share) prior to September 22, 2026. The filing explicitly states the reverse split was \"intended to ensure compliance with the Bid Price Rule as well as other conditions required by the Panel\" to avoid immediate delisting. This is a material disclosure of delisting risk and the company's remedial action to address it.","company_name":"HCW Biologics Inc.","ticker":"HCWB","filing_date":"2026-06-26","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":11477,"accession_number":"0001493152-26-030236","item_number":null,"item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"HCW Biologics disclosed a 1-for-6 reverse stock split effectuated in direct response to a Nasdaq Hearings Panel decision letter (May 29, 2026) that threatened \"automatic delisting\" if the company failed to maintain compliance with the Bid Price Rule (minimum $1.00 per share) prior to September 22, 2026. The filing explicitly states the reverse split was \"intended to ensure compliance with the Bid Price Rule as well as other conditions required by the Panel\" to avoid immediate delisting. This is a material disclosure of delisting risk and the company's remedial action to address it.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T13:01:37.895902+00:00","company_name":"HCW Biologics Inc.","ticker":"HCWB","filing_date":"2026-06-26"}]}